Blog
RSS FeedPosted by Michael Wonder on 16 Aug 2021
PHARMAC must explain funding decisions
16 August 2021 - “A report this morning that all PHARMAC staff, rather than clinical experts or those with patient ...
Posted by Michael Wonder on 30 Jul 2021
2021 October price disclosure cycle – indicative prices
30 August 2021 - Indicative 1 October 2021 prices resulting from the 2021 October Cycle of Price Disclosure have now ...
Posted by Michael Wonder on 28 Jul 2021
PHARMAC releases drug wish-list to be more 'transparent' but advocates say it gives false hope
28 July 2021 - PHARMAC has for the first time released a list of all the drugs it wants to ...
Posted by Michael Wonder on 28 Jul 2021
PHARMAC commits to being more transparent
28 July 2021 - For the first time, PHARMAC is sharing its priority lists for all funding applications for medicines ...
Posted by Michael Wonder on 23 Jun 2021
Price disclosure 2021 October cycle outcomes summary
23 June 2021 - The summary of price disclosure price reductions for the 2021 October cycle has now been published. ...
Posted by Michael Wonder on 08 Mar 2021
Department of Health publishes Public Summary Document for medicine without a published outcome
8 March 2021 - The Department of Health has published a Public Summary Document for mometasone furoate with indacaterol maleate ...
Posted by Michael Wonder on 08 Mar 2021
More startling revelations from the Public Summary Document for upadacitinib monohydrate (Rinvoq)
8 March 2021 - Take a seat before reading any further. ...
Posted by Michael Wonder on 01 Feb 2021
Patient advocate slams cancer agency report over 'wall of silence' on PHARMAC funding
2 February 2021 - The Cancer Control Agency has released its first report into cancer in New Zealand, but one patient ...
Posted by Michael Wonder on 20 Jan 2021
2021 April price disclosure cycle – indicative prices
20 January 2021 - Indicative 1 April 2021 prices resulting from the 2021 April Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 12 Nov 2020
PHARMAC won’t release the data that changed its mind on diabetes
13 November 2020 - Diabetes Foundation Aotearoa will request the Ombudsman investigate the refusal by PHARMAC to release public submissions ...
Posted by Michael Wonder on 06 Oct 2020
1 October 2020 price disclosure - confirmed prices
6 October 2020 - Confirmed 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure has now been ...
Posted by Michael Wonder on 01 Sep 2020
Update on the agenda for the November 2020 PBAC meeting
1 September 2020 - Less than one week in and the agenda for the next scheduled PBAC meeting has already been ...
Posted by Michael Wonder on 24 Aug 2020
Insights from the July 2020 PBAC meeting - Insight #2 (agenda)
25 August 2020 - Agenda items are revised with no indication of what has been changed. ...
Posted by Michael Wonder on 28 Jul 2020
2020 October price disclosure cycle – indicative prices
28 July 2020 - Indicative 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 23 Jul 2020
PBAC statement of endorsement for transparency measures and standardised redactions to public summary documents
23 July 2020 - The PBAC has made a statement outlining its support for measures to improve the transparency of ...